Skip to main content
SpringerLink
Log in

Glycaemia Control in Diabetes Mellitus

Towards The Normal Profile?

  • Practical Therapeutic
  • Published:
Drugs Aims and scope Submit manuscript

Summary

The Diabetes Control and Complications Trial and the Stockholm Study have conclusively demonstrated that improving the blood glucose control in patients with insulin-dependent diabetes mellitus (IDDM) reduces the risk of developing retinopathy, nephropathy and neuropathy. Each patient with IDDM should be carefully evaluated for the appropriateness of institution of an intensive insulin treatment programme. In particular, the risk of severe hypoglycaemia must be considered and the goals modified if necessary to reduce the risk.

Successful implementation of an intensive treatment programme requires an experienced healthcare team and a knowledgeable and well motivated cooperative patient. Several variations of intensive treatment programmes can be used, with no definite superiority of one treatment method over the others. Individualisation is the key to success. Each programme has the same general principles. Regular insulin is used to control the postprandial glucose excursion and a slow infusion of regular insulin by a pump or injected intermediate or long-acting insulin is used to balance fasting glucose utilisation and production.

The treatment will not be successful without self-monitoring of blood glucose by the patient and frequent adjustment of the insulin doses to compensate for variations in blood glucose levels, diet and activity. The treatment should be followed with quarterly glycated haemoglobin determinations and a regular follow-up plan. During follow-up the main challenge for the healthcare team will be to maintain motivation in the patient and to assist with behaviour modification. A detailed understanding of intensive treatment programmes may be beyond the skill of the average primary care physician, but any physician caring for patients with diabetes will benefit from an understanding of the general treatment principles outlined in this article.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  • Amiel SA, Sherwin RS, Simonson DC, et al. Effect of intensive insulin therapy on glycemic thresholds for counterregulatory hormone release. Diabetes 37: 901–907, 1988

    Article  PubMed  CAS  Google Scholar 

  • Bantle JP, Weber MS, Rao SMS, et al. Rotation of the anatomic regions used for insulin injections and day to day variability of plasma glucose in type I diabetic subjects. Journal of the American Medical Association 263: 1802–1806, 1990

    Article  PubMed  CAS  Google Scholar 

  • Bantle JP, Neal L, Frankamp LM. Effects of the anatomical region used for insulin injections on glycemia in type I diabetes subjects. Diabetes Care 16: 1592–1599, 1993

    Article  PubMed  CAS  Google Scholar 

  • Berson SA, Yalow RS. Immunoassay of insulin. Antoniades H (Ed.) Hormones in human plasma. Little Brown, Boston, 1960

    Google Scholar 

  • Bliss M. The discovery of insulin, The University of Chicago Press, Chicago, 1982

    Google Scholar 

  • Chantelau E, Spraul M, Muhlhauser I, et al. Long-term safety. efficacy, and side-effects of continuous subcutaneous insulin infusion treatment for type I (insulin-dependent) diabetes: a one centre experience. Diabetologia 32: 421–426, 1989

    Article  PubMed  CAS  Google Scholar 

  • Crombach G, Siebolds M, Mies R. Insulin use in pregnancy: clinical pharmacokinetic considerations. Clinical Pharmacokinetics 24: 89–100, 1993

    Article  PubMed  CAS  Google Scholar 

  • Cryer PE. Perspective in diabetes: hypoglycemia begets hypoglycemia in IDDM. Diabetes 42: 1691–1693, 1993

    PubMed  CAS  Google Scholar 

  • Dahl-Jorgensen K, Brinchmann-Hansen O, Hanssen KF, et al. Rapid tightening of blood glucose control leads to transient deterioration of retinopathy in insulin dependent diabetes mellitus: the Oslo study. British Medical Journal 290: 811–815, 1985

    Article  PubMed  CAS  Google Scholar 

  • Diabetes Control and Complications Trial Research Group. The Diabetes Control and Complications Trial (DCCT): design and methodologic considerations for the feasibility phase. Diabetes 35: 530–545, 1986

    Article  Google Scholar 

  • Diabetes Control and Complications Trial Research Group. Epidemiology of severe hypoglycemia in the Diabetes Control and Complications Trial. American Journal of Medicine 90: 450–459, 1991

    Google Scholar 

  • Diabetes Control and Complications Trial Research Group. The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. New England Journal of Medicine 329: 977–986, 1993

    Article  Google Scholar 

  • Fanelli CG, Epifano L, Rambotti AM, et al. Meticulous prevention of hypoglycemia normalizes the glycemic thresholds and magnitude of most neuroendocrine responses to, symptoms of, and cognitive function during hypoglycemia in intensively treated patients with short-term IDDM. Diabetes 42: 1683–1689, 1993

    Article  PubMed  CAS  Google Scholar 

  • Havlin CE, Cryer PE. Nocturnal hypoglycemia does not result commonly in major hyperglycemia in patients with diabetes mellitus. Diabetes Care 10: 141–147, 1987

    Article  PubMed  CAS  Google Scholar 

  • Heine RJ, Bilo HJ, Fonk T, et al. Absorption kinetics and action profiles of mixtures of short and intermediate-acting insulins. Diabetologia 27: 558–562, 1984

    Article  PubMed  CAS  Google Scholar 

  • Henry RR, Wallace P, Gumbiner B, et al. Intensive conventional therapy for type II diabetes: metabolic effects during a 6-month outpatient trial. Diabetes Care 16: 21–31, 1993

    Article  PubMed  CAS  Google Scholar 

  • Howey DC, Hooper SA, Bowsher RR. [Lys (B28), Pro (B29)] —human insulin: an equipotent analogue of human insulin with rapid onset and short duration of action. Abstract no 1688. Diabetes 40 (Suppl. 1): 423A, 1991

    Google Scholar 

  • Koivisto VA, Felig P. Alterations in insulin absorption and in blood glucose control associated witb varying insulin injection sites in diabetic patients. Annals of Internal Medicine 92: 59–61, 1980

    PubMed  CAS  Google Scholar 

  • Kroc Collaborative Study Group. Glood glucose control and tbe evolution of diabetic retinopathy and albuminuria: a preliminary multicenter trial. New England Journal of Medicine 311: 365–372, 1984

    Article  Google Scholar 

  • Lasker RD. The diabetes control and complications trial: implications for policy and practice. New England Journal of Medicine 329: 1035–1036, 1993

    Article  PubMed  CAS  Google Scholar 

  • Lundbaek K. Diabetic angiopathy: a specific vascular disease. Lancet 1: 377, 1954

    Article  Google Scholar 

  • McCoughey ES, Betts PR, Rowe SD. Improved diabetic control in adolescents using the penject syringe for multiple insulin injections. Diabetic Medicine 3: 234–236, 1986

    Article  Google Scholar 

  • Miller E, Hare JW, Cloherty JP, et al. Elevated maternal hemoglobin A in early pregnancy and major congenital anomalies in infants of diabetic mothers. New England Journal of Medicine 304: 1441–1443, 1981

    Google Scholar 

  • Pugh JA, Ramirez G, Wagner MZ, et al. Is combination therapy with sulfonylurea an insulin therapy useful in NIDDM patients?: a meta-analysis. Diabetes Care 15: 953–959, 1992

    Article  PubMed  CAS  Google Scholar 

  • Reichard P, Nilsson B-Y, Rosenquist U. The effect of long-term intensified insulin treatment on tbe development of microvascular complications of diabetes mellitus. New England Journal of Medicine 329: 304–309, 1993

    Article  PubMed  CAS  Google Scholar 

  • Scheffrin A, Belmonte M. Multiple daily self-glucose monitoring: its essential role in long-term glucose control in insulin-dependent diabetic patients treated witb pump and multiple subcutaneous injections. Diabetes Care 5, 479–484, 1982

    Article  Google Scholar 

  • Seigler DE, Olsson GM, Agramonte RF, et al. Pharmacokinetics of long-acting (ultralente) insulin preparations. Diabetes, Nutrition, Metabolism 4: 267–273, 1991

    Google Scholar 

  • Selam J-L, Micossi P, Dunn F, et al. Large-scale, multicenter evaluation of a programmable implantable insulin pump in type I diabetes. Diabetes 40 (Suppl I): 424A, 1991

    Google Scholar 

  • Service FJ, Molnar GD, Rosevear JW, et al. Mean amplitude of glycemic excursions, a measure of diabetic instability. Diabetes 1970; 19: 644–655.

    PubMed  CAS  Google Scholar 

  • Steno Study Group. Effect of 6 months of strict metabolic control on eye and kidney function in insulin-dependent diabetics witb background retinopathy. Lancet 1: 121–124, 1982

    Article  Google Scholar 

  • Stout RW. Insulin and atberoma: 20-yr prospective. Diabetes Care 13: 631–654, 1990

    Article  PubMed  CAS  Google Scholar 

  • Taskinen M-R, Kuusi T, Helve E, et al. Insulin tberapy induces antiatherogenic changes of serum lipoproteins in noninsulin dependent diabetes. Arteriosclerosis 8: 168–177, 1988

    Article  PubMed  CAS  Google Scholar 

  • UK Prospective Diabetes Study Group. UK Prospective Diabetes Study (UKPDS). UIII study design, progress and performance. Diabetologia 31: 877–890, 1991

    Article  Google Scholar 

  • White NH, Skor DA, Cryer PE, et al. Identification of type I diabetic patients at increased risk for hypoglycemia during intensive tberapy. New England Journal of Medicine 308: 485–491, 1983

    Article  PubMed  CAS  Google Scholar 

  • Zimmerman BR. Preventing long term complications: implications for combination tberapy witb acarbose. Drugs 44: 54–60, 1992

    Article  PubMed  Google Scholar 

  • Zimmerman BR, Service FJ. Management of non-insulin dependent diabetes mellitus. Medical Clinics of North America 72 (6): 1355–1364, 1988

    PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Endocrinology and Internal Medicine, Mayo Clinic, 200 First Street S.W., Rochester, Minnesota, 55905, USA

    Bruce R. Zimmerman

Authors
  1. Bruce R. Zimmerman
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Zimmerman, B.R. Glycaemia Control in Diabetes Mellitus. Drugs 47, 611–621 (1994). https://doi.org/10.2165/00003495-199447040-00005

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.2165/00003495-199447040-00005

Keywords

Search

Navigation